IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-76

  1. 8,422 Posts.
    lightbulb Created with Sketch. 1386
    By so doing, the directors have decoupled their remuneration from shareholder returns.
    They need to be reminded of that, often.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.335M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $2.546K 35.86K

Buyers (Bids)

No. Vol. Price($)
1 14158 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 14.37pm 31/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.